We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$1.59B
AUM Growth
+$283M
Cap. Flow
+$228M
Cap. Flow %
14.35%
Top 10 Hldgs %
6.1%
Holding
1,532
New
540
Increased
294
Reduced
266
Closed
432

Top Buys

Rank Stock Value
1
JCI icon
Johnson Controls International
JCI
+$11.9M
2
BMO icon
Bank of Montreal
BMO
+$10.5M
3
HPQ icon
HP
HPQ
+$9.75M
4
AER icon
AerCap
AER
+$9.53M
5
ITW icon
Illinois Tool Works
ITW
+$8.27M

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$8.73M
2
SYF icon
Synchrony
SYF
+$8.42M
3
CAH icon
Cardinal Health
CAH
+$7.63M
4
BRO icon
Brown & Brown
BRO
+$7.55M
5
UL icon
Unilever
UL
+$7.37M

Sector Composition

Rank Sector Weight
1 Technology 18.67%
2 Financials 17.36%
3 Industrials 17.08%
4 Consumer Discretionary 12.43%
5 Healthcare 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESNT icon
1051
Essent Group
ESNT
$6.14B
$209K 0.01%
+3,445
New +$199K
MDXG icon
1052
MiMedx Group
MDXG
$624M
$206K 0.01%
33,758
-41,185
-55% -$274K
NUS icon
1053
Nu Skin
NUS
$236M
$204K 0.01%
25,516
-23,372
-48% -$164K
WGS icon
1054
GeneDx Holdings
WGS
$2.46B
$204K 0.01%
+2,206
New +$173K
WLY icon
1055
John Wiley & Sons Class A
WLY
$2.53B
$201K 0.01%
4,513
-9,963
-69% -$420K
HLF icon
1056
Herbalife
HLF
$1.23B
$201K 0.01%
23,261
-156,610
-87% -$1.16M
ORIC icon
1057
Oric Pharmaceuticals
ORIC
$1.43B
$200K 0.01%
+19,668
New +$132K
AHCO icon
1058
AdaptHealth
AHCO
$770M
$195K 0.01%
20,719
-107,325
-84% -$947K
SBH icon
1059
Sally Beauty Holdings
SBH
$1.55B
$193K 0.01%
20,839
-19,002
-48% -$164K
RMAX icon
1060
RE/MAX Holdings
RMAX
$263M
$193K 0.01%
+23,548
New +$183K
AOMR
1061
Angel Oak Mortgage REIT
AOMR
$207M
$189K 0.01%
+20,071
New +$182K
GDYN icon
1062
Grid Dynamics Holdings
GDYN
$632M
$188K 0.01%
+16,305
New +$214K
ACVA icon
1063
ACV Auctions
ACVA
$1.35B
$188K 0.01%
+11,607
New +$181K
ZYME icon
1064
Zymeworks
ZYME
$1.77B
$188K 0.01%
+14,985
New +$179K
TCMD icon
1065
Tactile Systems Technology
TCMD
$555M
$188K 0.01%
18,537
-7,781
-30% -$88.9K
ZIMV
1066
DELISTED
ZimVie
ZIMV
$184K 0.01%
+19,660
New +$180K
ACH
1067
Accendra Health
ACH
$93.1M
$180K 0.01%
19,780
-107,846
-85% -$795K
EVH icon
1068
Evolent Health
EVH
$471M
$178K 0.01%
15,825
-20,865
-57% -$192K
CRCT icon
1069
Cricut
CRCT
$1.23B
$178K 0.01%
+26,271
New +$150K
SRPT icon
1070
Sarepta Therapeutics
SRPT
$1.94B
$174K 0.01%
10,193
+88
+0.9% +$3.75K
MNKD icon
1071
MannKind Corp
MNKD
$1.24B
$174K 0.01%
46,407
+31,051
+202% +$137K
SHYF
1072
DELISTED
The Shyft Group
SHYF
$173K 0.01%
+13,813
New +$135K
INTR icon
1073
Inter&Co
INTR
$2.23B
$172K 0.01%
+23,100
New +$154K
CMRC
1074
Commerce.com Inc Series 1
CMRC
$179M
$171K 0.01%
34,130
+17,631
+107% +$90.8K
INVX
1075
Innovex International
INVX
$2.13B
$171K 0.01%
+10,924
New +$168K

Similar funds

Campbell & Co Investment Adviser's Q2 2025 Portfolio in Review

As of Q2 2025, Campbell & Co Investment Adviser held 1,532 positions worth $1.59B, up 22% from $1.3B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Campbell & Co Investment Adviser deployed $228M of net new capital in Q2 2025, opening 540 new positions and adding to 294 existing holdings. Its largest new stake was Johnson Controls International: 128,951 shares worth $13.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 9.9% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cardinal Health, an estimated $7.63M trimmed.

  • Campbell & Co Investment Adviser's largest Q2 2025 buy was Johnson Controls International: 128,951 shares worth $13.6M.
  • Campbell & Co Investment Adviser added most to Dover in Q2 2025, an estimated $7.63M increase.
  • Campbell & Co Investment Adviser's biggest Q2 2025 reduction was Cardinal Health, cutting an estimated $7.63M.
  • Campbell & Co Investment Adviser fully exited Labcorp in Q2 2025, selling an estimated $8.73M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 6.1% of its $1.59B portfolio in Q2 2025.
  • Campbell & Co Investment Adviser opened 540 new positions and closed 432 in Q2 2025.
  • Campbell & Co Investment Adviser's portfolio value rose 22% quarter-over-quarter to $1.59B.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2025, filed 7 Aug 2025.